#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Univentricular heart Glomerulonephritis rapidly progressive Obliterative bronchiolitis Primary hyperoxaluria Vascular malformation Burkitt's lymphoma refractory Heavy menstrual bleeding Barth syndrome Colon cancer IPEX syndrome Epidermolysis bullosa Hereditary angioedema T-cell type acute leukaemia Salivary gland cancer Blastic plasmacytoid dendritic cell neoplasia More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Diagnostics Hairy cell leukaemia recurrent – Life with Disease Castleman’s disease – Treatment Retinoblastoma – Basic Information Alexander disease – Treatment Familial amyotrophic lateral sclerosis Chondrosarcoma – Basic Information Biotinidase deficiency Synovial sarcoma – Trials in Disease Advanced systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lolium Perenne Pollen Extract Haemophilus Influenzae AMLENETUG Ferumoxytol Aminohippuric Acid Nelarabine Danicopan IDROXIOLEIC ACID Alogliptin Ribonucleic Acid K30 Vinblastine Sulfate Maraviroc Balcinrenone Elenestinib Phosphate Esketamine Hydrochloride OXYBUTYNIN HYDROCHLORIDE Dersimelagon Phosphate FG001 Retinol Acetate GSK4524101A More therapies…

    Learn about Your Condition

    HER2 positive breast cancer Encephalitis autoimmune Eyelid ptosis Ependymoma C3 glomerulopathy Biliary tract disorder Atopic keratoconjunctivitis Pleomorphic leiomyosarcoma Anaplastic thyroid cancer Shprintzen-Goldberg syndrome Microscopic polyangiitis Onychomycosis Urethral stenosis Eosinophilic gastritis Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Via Trabucco 180, Palermo, 90146, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    2 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    Austria Bulgaria Germany Ireland Italy Poland

  • Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Epcoritamab
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicle centre lymphoma follicular grade I II – III refractory
    Investigated Drugs:
    • Epcoritamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia Denmark France Germany +8

  • Study on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Donidalorsen
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Rituximab
    • Zanubrutinib
    Austria Denmark France Italy Norway Spain +1

  • Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium Bulgaria Croatia Czechia Denmark France +11

  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Imatinib
    • Ponatinib
    Austria France Greece Italy Poland Spain

  • Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Cyclophosphamide
    • Doxorubicin
    Austria Belgium Czechia France Germany Italy +3

  • Study of Pegcetacoplan (APL-2) in Patients with Transplant-associated Thrombotic Microangiopathy After Stem Cell Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thrombotic microangiopathy
    France Greece Italy Spain

  • Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Rituximab
    • Zanubrutinib
    Austria Belgium France Germany Ireland Italy +5
Previous Page
1 … 6 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!